Ask AI
Public Law114th CongressHealth
S. 2512Became Law

Adding Zika Virus to the FDA Priority Review Voucher Program Act

This bill became law

Filed
Comm.
Floor
Both
Law

What it doesSummary public law (Apr 19, 2016)

(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.

What just happenedApr 19, 2016

Became Public Law No: 114-146.

Who’s behind it

Sen. Franken, Al [D-MN](D-MN)Sponsor
11 cosponsors7 D4 R
Read on Congress.gov
11cosponsors2committees24actions1related bills3subjects
  1. Apr 19, 2016President

    Became Public Law No: 114-146.

  2. Apr 19, 2016BecameLaw36000

    Became Public Law No: 114-146.

  3. Apr 19, 2016President

    Signed by President.

  4. Apr 19, 2016BecameLaw36000

    Signed by President.

  5. Apr 14, 2016Floor

    Presented to President.

  6. Apr 14, 2016President28000

    Presented to President.

  7. Apr 12, 2016FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  8. Apr 12, 2016FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1602)

  9. Apr 12, 2016Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1602)

  10. Apr 12, 2016FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on S. 2512.

  11. Apr 12, 2016FloorH30000

    Considered under suspension of the rules. (consideration: CR H1602-1605)

  12. Apr 12, 2016FloorH30300

    Mrs. Brooks (IN) moved to suspend the rules and pass the bill.

  13. Mar 25, 2016Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  14. Mar 21, 2016IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  15. Mar 21, 2016FloorH14000

    Received in the House.

  16. Mar 18, 2016Floor

    Message on Senate action sent to the House.

  17. Mar 17, 2016Floor

    Passed Senate with an amendment by Unanimous Consent. (consideration: CR S1606-1607; text as passed Senate: CR S1606)

  18. Mar 17, 2016Floor17000

    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(consideration: CR S1606-1607; text as passed Senate: CR S1606)

  19. Mar 15, 2016Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.

  20. Mar 15, 2016Committee

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  21. Mar 15, 2016Committee14000

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  22. Mar 9, 2016Committee

    Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Health, Education, Labor, and Pensions Committee
  23. Feb 8, 2016IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  24. Feb 8, 2016IntroReferral10000

    Introduced in Senate

Public LawApr 19, 201649

(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.

Passed House without amendmentApr 12, 201681

(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.

Passed Senate amendedMar 17, 201635

(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.

Reported to Senate with amendment(s)Mar 15, 20161

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.

Introduced in SenateFeb 8, 2016

Adding Zika Virus to the FDA Priority Review Voucher Program Act

This bill amends the Federal Food, Drug, and Cosmetic Act to add the Zika virus to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)
Adding Zika Virus to the FDA Priority Review Voucher Program Act — Informed